These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 26103929)

  • 21. Heparin-bonded stent-graft for the treatment of TASC II C and D femoropopliteal lesions: the Viabahn-25 cm trial.
    Zeller T; Peeters P; Bosiers M; Lammer J; Brechtel K; Scheinert D; Rastan A; Noory E; Beschorner U
    J Endovasc Ther; 2014 Dec; 21(6):765-74. PubMed ID: 25453876
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Angioplasty or bypass for superficial femoral artery disease? A randomised controlled trial.
    van der Zaag ES; Legemate DA; Prins MH; Reekers JA; Jacobs MJ
    Eur J Vasc Endovasc Surg; 2004 Aug; 28(2):132-7. PubMed ID: 15234692
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primary balloon expandable polytetrafluoroethylene-covered stenting of focal infrarenal aortic occlusive disease.
    Bruijnen RC; Grimme FA; Horsch AD; Van Oostayen JA; Zeebregts CJ; Reijnen MM
    J Vasc Surg; 2012 Mar; 55(3):674-8. PubMed ID: 22112555
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Midterm follow-up of balloon-expandable ePTFE endografts in the femoropopliteal segment.
    Hagenaars T; Gussenhoven EJ; Smeets L; Moll FL; Buth J; Nevelsteen A; van Dijk LC; van Sambeek MR; van Urk H
    J Endovasc Ther; 2002 Aug; 9(4):428-35. PubMed ID: 12223002
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Factors determining late patency of aortobifemoral bypass graft].
    Davidović LB; Lotina SI; Kostić DM; Cinara II; Cvetković SD; Stojanov PL; Velimirović DB; Marković MM; Pejkić SA; Vukotić AM
    Srp Arh Celok Lek; 1997; 125(1-2):24-35. PubMed ID: 17974352
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Results of heparin-bonded ePTFE-covered stents for chronic occlusive superficial femoral artery disease.
    Lensvelt MM; Fritschy WM; van Oostayen JA; Holewijn S; Zeebregts CJ; Reijnen MM
    J Vasc Surg; 2012 Jul; 56(1):118-25. PubMed ID: 22342154
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of Viabahn in the treatment of severe superficial femoral artery lesions: which factors influence long-term patency?
    Alimi YS; Hakam Z; Hartung O; Boufi M; Barthèlemy P; Aissi K; Dubuc M
    Eur J Vasc Endovasc Surg; 2008 Mar; 35(3):346-52. PubMed ID: 17983772
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical failure after percutaneous transluminal angioplasty of the superficial femoral and popliteal arteries.
    Karch LA; Mattos MA; Henretta JP; McLafferty RB; Ramsey DE; Hodgson KJ
    J Vasc Surg; 2000 May; 31(5):880-7. PubMed ID: 10805877
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polytetrafluoroethylene covered stent placement for focal occlusive disease of the infrarenal aorta.
    Grimme FA; Reijnen MM; Pfister K; Martens JM; Kasprzak P
    Eur J Vasc Endovasc Surg; 2014 Nov; 48(5):545-50. PubMed ID: 25218651
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Durability of renal artery stents in patients with transrenal abdominal aortic endografts.
    Baril DT; Lookstein RA; Jacobs TS; Won J; Marin ML
    J Vasc Surg; 2007 May; 45(5):915-20; discussion 920-1. PubMed ID: 17391902
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term follow-up of endoluminal grafting for aneurysmal and occlusive disease in the superficial femoral artery.
    Rodriguez-Lopez JA; Soler L; Werner A; Martinez E; Papazoglou K; Diethrich EB
    J Endovasc Surg; 1999 Aug; 6(3):270-7. PubMed ID: 10495156
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of covered stent placement for central venous occlusive disease in hemodialysis patients.
    Anaya-Ayala JE; Smolock CJ; Colvard BD; Naoum JJ; Bismuth J; Lumsden AB; Davies MG; Peden EK
    J Vasc Surg; 2011 Sep; 54(3):754-9. PubMed ID: 21664095
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Femorofemoral bypass graft: analysis of patency and factors influencing long-term outcome.
    Criado E; Burnham SJ; Tinsley EA; Johnson G; Keagy BA
    J Vasc Surg; 1993 Sep; 18(3):495-504; discussion 504-5. PubMed ID: 8377244
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Percutaneous treatment of long superficial femoral artery occlusive disease: efficacy of the Hemobahn stent-graft.
    Bray PJ; Robson WJ; Bray AE
    J Endovasc Ther; 2003 Jun; 10(3):619-28. PubMed ID: 12932177
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of above-the-knee prosthetic femoro-popliteal bypass versus percutaneous transluminal angioplasty and stenting for treatment of occlusive superficial femoral artery disease.
    Linnakoski H; Uurto I; Suominen V; Vakhitov D; Salenius J
    Scand J Surg; 2013; 102(4):227-33. PubMed ID: 24056137
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Endovascular therapy of abdominal aortic aneurysm: results of a mid-term follow-up].
    Pitton MB; Schweitzer H; Herber S; Schmiedt W; Neufang A; Düber C; Thelen M
    Rofo; 2003 Oct; 175(10):1392-402. PubMed ID: 14556109
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Use of stents with bioactive coating in treatment of patients with lesions of the superficial femoral artery].
    Generalov MI; Maĭstrenko DN; Oleshchuk AN; Ivanov AS; Granov DA; Ovchinnikov IV; Khmel'nitskiĭ AV; Gusinskiĭ AV
    Angiol Sosud Khir; 2016; 22(3):59-64. PubMed ID: 27626251
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of the biodegradable peripheral Igaki-Tamai stent in the treatment of de novo lesions in the superficial femoral artery: the GAIA study.
    Werner M; Micari A; Cioppa A; Vadalà G; Schmidt A; Sievert H; Rubino P; Angelini A; Scheinert D; Biamino G
    JACC Cardiovasc Interv; 2014 Mar; 7(3):305-12. PubMed ID: 24529932
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Remote superficial femoral artery endarterectomy and distal aSpire stenting: multicenter medium-term results.
    Rosenthal D; Martin JD; Schubart PJ; Wellons ED; Shuler FW; Levitt AB
    J Vasc Surg; 2004 Jul; 40(1):67-72. PubMed ID: 15218464
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Three-year outcome of the heparin-bonded Viabahn for superficial femoral artery occlusive disease.
    Golchehr B; Kruse R; van Walraven LA; Lensvelt MM; Zeebregts CJ; Reijnen MM
    J Vasc Surg; 2015 Oct; 62(4):984-9. PubMed ID: 26059093
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.